Cargando…

Long-Term Control of Human Immunodeficiency Virus-1 Replication Despite Extensive Resistance to Current Antiretroviral Regimens: Clonal Analysis of Resistance Mutations in Proviral Deoxyribonucleic Acid

Archived resistance mutations compromise antiretroviral treatment. We have investigated 3 selected aviremic patients who had extensive historical resistance to their current regimen. All 3 patients underwent unstructured treatment interruptions associated to the re-emergence of wild-type virus befor...

Descripción completa

Detalles Bibliográficos
Autores principales:	Stella-Ascariz, Natalia, Montejano, Rocio, Martin-Vicente, María, Mingorance, Jesús, Pérez-Valero, Ignacio, Bernardino, José I., Arribas, Jose R.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2016
Materias:	Brief Reports
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4800466/ https://www.ncbi.nlm.nih.gov/pubmed/27006965 http://dx.doi.org/10.1093/ofid/ofw041

Ejemplares similares

Persistence of Human Immunodeficiency Virus-1 Drug Resistance Mutations in Proviral Deoxyribonucleic Acid After Virologic Failure of Efavirenz-Containing Antiretroviral Regimens
por: De La Cruz, Justin, et al.
Publicado: (2019)

An antiretroviral drug-naïve human immunodeficiency virus-1 infected woman with a persistent non-reactive proviral deoxyribonucleic acid polymerase chain reaction: a case report
por: Kfutwah, Anfumbom KW, et al.
Publicado: (2013)

Inflammatory, procoagulant markers and HIV residual viremia in patients receiving protease inhibitor monotherapy or triple drug therapy: a cross-sectional study
por: Estébanez, Miriam, et al.
Publicado: (2014)

Undetectable proviral deoxyribonucleic acid in an adolescent perinatally infected with human immunodeficiency virus-1C and on long-term antiretroviral therapy resulted in viral rebound following antiretroviral therapy termination: A case report with implications for clinical care
por: Koofhethile, Catherine Kegakilwe, et al.
Publicado: (2019)

Assessment of Noninvasive Markers of Steatosis and Liver Fibrosis in Human Immunodeficiency Virus-Monoinfected Patients on Stable Antiretroviral Regimens
por: Busca, C, et al.
Publicado: (2022)

Optimizing Antiretroviral Therapy in Heavily ART-Experienced Patients with Multi-Class Resistant HIV-1 Using Proviral DNA Genotypic Resistance Testing
por: Rauschning, Dominic, et al.
Publicado: (2023)

Impact of preexisting nucleos(t)ide reverse transcriptase inhibitor resistance on the effectiveness of bictegravir/emtricitabine/tenofovir alafenamide in treatment experience patients
por: Micán, Rafael, et al.
Publicado: (2022)

135 HIV-associated immunodeficiency despite potent antiretroviral therapy with CD4 T cell reconstitution
por: Poonia, Bhawna, et al.
Publicado: (2014)

Usefulness of Integrase resistance testing in proviral HIV-1 DNA in patients with Raltegravir prior failure
por: Fernández-Caballero, Jose Ángel, et al.
Publicado: (2016)

Impact of Raltegravir or Efavirenz on Cell-Associated Human Immunodeficiency Virus-1 (HIV-1) Deoxyribonucleic Acid and Systemic Inflammation in HIV-1/Tuberculosis Coinfected Adults Initiating Antiretroviral Therapy
por: Delagreverie, Héloïse M, et al.
Publicado: (2020)

Inferring Human Immunodeficiency Virus 1 Proviral Integration Dates With Bayesian Inference
por: Jones, Bradley R, et al.
Publicado: (2023)

108. Selective Decay of Intact HIV-1 Proviral DNA on Antiretroviral Therapy
por: Gandhi, Rajesh, et al.
Publicado: (2020)

Increased Proviral DNA in Circulating Cells Correlates with Plasma Viral Rebound in Simian Immunodeficiency Virus-Infected Rhesus Macaques after Antiretroviral Therapy Interruption
por: Ziani, Widade, et al.
Publicado: (2021)

Genome-wide Determinants of Proviral Targeting, Clonal Abundance and Expression in Natural HTLV-1 Infection
por: Melamed, Anat, et al.
Publicado: (2013)

An Improved Sequencing-Based Bioinformatics Pipeline to Track the Distribution and Clonal Architecture of Proviral Integration Sites
por: Rosewick, Nicolas, et al.
Publicado: (2020)

Preliminary In Vivo Evidence of Reduced Synaptic Density in Human Immunodeficiency Virus (HIV) Despite Antiretroviral Therapy
por: Weiss, Julian J, et al.
Publicado: (2021)

Feasibility of testing and detection of HIV-1 drug resistance in proviral DNA
por: Booth, Clare L, et al.
Publicado: (2014)

HIV-1C proviral DNA for detection of drug resistance mutations
por: Huruy, Kahsay, et al.
Publicado: (2018)

Detection of feline immunodeficiency proviral DNA in peripheral blood lymphocytes by the polymerase chain reaction
por: Hohdatsu, T., et al.
Publicado: (1992)

Clonality, virulence determinants, and profiles of resistance of clinical Acinetobacter baumannii isolates obtained from a Spanish hospital
por: Dahdouh, Elias, et al.
Publicado: (2017)

On the Mechanism of Integration of Transforming Deoxyribonucleate
por: Fox, Maurice S.
Publicado: (1966)

Correlation between blood telomere length and CD4+ CD8+ T-cell subsets changes 96 weeks after initiation of antiretroviral therapy in HIV-1–positive individuals
por: Chalouni, Mathieu, et al.
Publicado: (2020)

Virological Failure and Acquired Genotypic Resistance Associated With Contemporary Antiretroviral Treatment Regimens
por: Rhee, Soo-Yon, et al.
Publicado: (2020)

Antiretroviral Regimen and Suboptimal Medication Adherence Are Associated With Low-Level Human Immunodeficiency Virus Viremia
por: Konstantopoulos, Christina, et al.
Publicado: (2015)

Comparison of Two Antiretroviral Therapy Regimens in Human Immunodeficiency Virus (HIV−) Infected Pregnant Women
por: Tate, Danielle, et al.
Publicado: (2017)

Correction: HIV-1C proviral DNA for detection of drug resistance mutations
por: Huruy, Kahsay, et al.
Publicado: (2018)

Use of Proviral DNA to Investigate Virus Resistance Mutations in HIV-infected Zimbabweans
por: Musingwini, Tutsirai V., et al.
Publicado: (2017)

HIV-1 re-suppression on a first-line regimen despite the presence of phenotypic drug resistance
por: Basson, Adriaan E., et al.
Publicado: (2020)

Dolutegravir plus lamivudine for maintenance of HIV viral suppression in adults with and without historical resistance to lamivudine: 48-week results of a non-randomized, pilot clinical trial (ART-PRO)
por: De Miguel, Rosa, et al.
Publicado: (2020)

Human Immunodeficiency Virus and Clonal Hematopoiesis
por: Vorri, Stamatia C., et al.
Publicado: (2023)

Effect of HIV infection and antiretroviral therapy initiation on genome-wide DNA methylation patterns
por: Esteban-Cantos, Andrés, et al.
Publicado: (2023)

Genotyping and antiretroviral drug resistance of human immunodeficiency Virus-1 in Jazan, Saudi Arabia
por: Zaki, Eitezaz A., et al.
Publicado: (2020)

Resistance Trends of Antiretroviral Agents in People with Human Immunodeficiency Virus in Korea, 2012 - 2020
por: Oh, Sang-Min, et al.
Publicado: (2023)

The Localization of Deoxyribonucleic Acid in Escherichia coli
por: Caro, Lucien G., et al.
Publicado: (1958)

MOLECULAR STRUCTURE OF DEOXYRIBONUCLEIC ACID (DNA)
por: Langridge, R., et al.
Publicado: (1957)

Time to virologic failure for patients taking their first antiretroviral regimen and the subsequent resistance profiles
por: Crouzat, Frederic, et al.
Publicado: (2014)

Antiretroviral Treatment Simplification With 2-Drug Regimens: Impact of Transmitted Drug Resistance Mutations
por: Kessler, Harald H, et al.
Publicado: (2019)

Strong, but Age-Dependent, Protection Elicited by a Deoxyribonucleic Acid/Modified Vaccinia Ankara Simian Immunodeficiency Virus Vaccine
por: Chamcha, Venkateswarlu, et al.
Publicado: (2016)

HIV Drug Resistance Mutations in Proviral DNA from a Community Treatment Program
por: Derache, Anne, et al.
Publicado: (2015)

Deoxyribonucleic Acid 5-Hydroxymethylation in Cell-Free Deoxyribonucleic Acid, a Novel Cancer Biomarker in the Era of Precision Medicine
por: Xu, Ling, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_05ifh2hign0vodd9nkdr576fb8